International Stem Cell Corporation Announces Second Patient with Parkinson’s Disease Treated in Phase I Clinical Trial
International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease
International Stem Cell Corporation and Rohto Pharmaceutical Enter Second Stage of Research Agreement
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring
